Aim: Asymmetric dimethylarginine(ADMA) is an endogenous inhibitor of nitric oxide synthase(eNOS), which can compete against L- Arginine for binding the active site of NOS, and reduce the synthesize of NO.

• 背景:不对称二甲基精氨酸(asymmetric dimethylarginine, ADMA)是一氧化氮合酶(NOS)的内源性抑制剂,可与L-精氨酸竞争性结合NOS活性部位,减少NO合成。